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Abstract: Surgical treatment to restore full range of motion and full weight bearing after extensive
femoral bone resection in patients with primary or metastatic femoral tumours is individually challenging.
Especially when the remaining distal or proximal bone is very short, a rigid fixation of an implant is
difficult to achieve due to the reverse funnel shape of the metaphysis. Herein, we present a novel implant
design using a spreading mechanism in the distal part of the prosthesis for rigid, uncemented fixation
in the remaining femoral bone after extensive tumour resection of the femur. We present the outcome
of 5 female patients who underwent implantation of this spreading stem after extensive proximal or
distal femoral bone resection. There was no radiological or clinical loosening or implant-related revision
surgery in our follow-up (mean 21.46 months, range 3.5-46 months). This uncemented spreading stem may
therefore represent an alternative option for fixation of a prosthetic device in the remaining metaphyseal
femur.
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Surgical treatment to restore full range of motion and full weight bearing after extensive femoral bone resection in patients with
primary or metastatic femoral tumours is individually challenging. Especially when the remaining distal or proximal bone is very
short, a rigid fixation of an implant is difficult to achieve due to the reverse funnel shape of the metaphysis. Herein, we present
a novel implant design using a spreading mechanism in the distal part of the prosthesis for rigid, uncemented fixation in the
remaining femoral bone after extensive tumour resection of the femur.We present the outcome of 5 female patients who underwent
implantation of this spreading stem after extensive proximal or distal femoral bone resection. There was no radiological or clinical
loosening or implant-related revision surgery in our follow-up (mean 21.46 months, range 3.5–46 months). This uncemented
spreading stem may therefore represent an alternative option for fixation of a prosthetic device in the remaining metaphyseal
femur.
1. Introduction
Primary bone tumours or metastatic lesions of the femur
may represent a remarkable surgical challenge, particularly in
reconstructing the full weight bearing function of the lower
limb with a good pain relief. With extensive bone resections,
treatment options such as allograft-prostheses composites,
rotationplasty, and endoprosthetic reconstruction by custom
made devices or modular systems are well established.
Although these options offer a wide spectrum of appli-
cations, postoperative complications were observed [1, 2],
including fractures and aseptic stem loosening of the pros-
thetic implants. In the literature, the incidence of aseptic
loosening after cemented massive prostheses is described
within 0–6% [3, 4] and is known as a midterm complication
due to anatomical location and dimension of resection as
well as the age of the patient [5]. If the remaining bone
after resection consists only in the short femoral metaph-
ysis, a rigid fixation of the implant is even more difficult
to achieve due to the reversed funnel-shaped anatomy of
the metadiaphyseal part of the distal/proximal femur. Unwin
et al. [6] postulated the bending moment of the femur, which
is related to the offset distance (in the proximal femur higher
than in the distal femur) between the long axis of the femur
and a line passing from the femoral head to the knee joint,
to be another reason for stem loosening. Mechanical analysis
showed a decreasing moment from 140Nm at the level of the
greater trochanter to almost zero at the level of the insertion
of the anterior cruciate ligament around a dorsiventral axis
with increasing moment to a great extent during weight
bearing [7] and a transmission of 60% of the applied load
on the cemented intramedullary stem to the region of the tip
of the stem. Therefore, multiple statements about alternative
reconstructions, especially concerning the problemwith rigid
fixation in short remaining proximally or distally femoral
bones, ask for an increasing demand in more innovative
modular implants.
Accordingly, we investigated a novel prosthetic design
using a spreading mechanism of the distal/proximal part of
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Figure 1: Tip of the spreading stem.
Figure 2: Tip of the spreading stem with open fins.
the prostheses for rigid, uncemented fixation in the remain-
ing bone after extensive tumour resection of the femur.
2. Materials and Methods
2.1. Patient Population. BetweenNovember 2010 andDecem-
ber 2011, 5 female patients underwent extensive proximal,
diaphyseal, or distal femoral resections and implantation
of an uncemented femoral spreading stem (ArgoMedical,
Zug, Switzerland) (Figure 1). Three patients had metasta-
sis at diagnosis, one patient presented with a pathological
fracture, and one patient had overt systemic metallosis from
prior surgeries associated with prosthetic infection. Two of
these patients suffered from osteosarcoma and each one
suffered from Ewing’s sarcoma, undifferentiated sarcoma,
and metastatic breast carcinoma, respectively. The average
age at the time of surgery was 52 years (range 30 to 82
years). Patients were followed up clinically using the MSTS-
Score (musculoskeletal society tumour score) and the TESS-
Score (Toronto extremity salvage score) as well as radiological
imaging to evaluate rigid fixation postoperatively.
2.2. Surgical Technique and Biomechanical Considerations.
After resection of the tumour-affected part of the femur,
the end of the wide part of the area of the noningrowth
region of the prosthesis above the ingrowth rigid fluted stem
abuts at the remaining distal femur end cylinder in order
to achieve the best possible apposition to the shaft after
spreading the distal flat fins.The spreading flat hydroxyapatite
coated fins (Figure 2) are fashioned by corundum in order to
achieve surface enhancement. The nonspreading part of the
prostheses, anchoring in the medullary cavity, is constructed
by a primary layer of titan covered by a hydroxyapatite layer.
Therefore after the osteotomy, the medullary cavity is reamed
in a cylindrical shape of 14, 16, or 18 millimetres (mm) of
diameter. The depth of the reamed part should be at least
12 centimetres measured from the osteotomy. After double-
checking the length of the final prostheses, the stem is adapted
into its final position and an Allen wrench is inserted into the
hexagon socket of the grub screw placed on the neck of the
prostheses. The screw is then turned to achieve a rearward
movement of the expanding rod and its guiding bolt. This
Figure 3: Postoperative X-ray of the implanted spreading stem.
leads to spreading of the stem with inward movement by
the cone shaped tip of the expanding bolt. The six blades
of the stem, each of them 70mm long and hydroxyapatite-
coated, are infinitely adjustable.The grub screw has a locking
mechanism if the implant is spread to a total angle of 30∘
on both sides measured from the midline of the prostheses.
Biomechanically, a force of 46 kilograms is needed to spread
the fins, which is then directly transferred to the surrounding
bone. In the surrounding metaphyseal bone, a theoretically
maximal spreading force of 2500 kilograms can be generated
until the grub screw fails. In practice, fixation strength
can be individually adapted and should not be overused
because the bone may fail first. Verification of fully spread
fins under image intensifier shows adequate opening of the
lamellae. Rigid fixation is primarily achieved by deadlock of
the spreading fins to the surrounding bone and secondarily
by the bony ongrowth to the fins. The intramedullary stem
diameter is available in diameters of 14, 16, or 18mm and has
a total length of 120mm.The prosthetic neckpiece is 150mm
long with an extension module of 65mm. Figure 3 shows the
X-ray after implantation of an uncemented femoral stem as
used in our series.
2.3. Postoperative Rehabilitation. Postoperative rehabilitation
was as follows: toe touch weight bearing for the first six weeks
followed by gradual increase of weight bearing for the next
six weeks and no rotational forces during the entire three
months.
3. Results
In four out of five cases the TESS- and MSTS-Scores were
evaluated between 9.5 and up to 46 months postoperatively.
One patient died prior to evaluation of these scores due
to metastatic disease. Conventional radiographic evaluation
was accomplished from 3.5 months to 46 months (mean
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1 61 Breast carcinoma Proximal femur Distal 27∗ 24 23.3
2 82 Undifferentiated sarcoma Diaphyseal femur Distal and proximal 25∗ 77.3 63.3
3 35 Osteosarcoma Proximal femur Distal 3.5∗ n.a. n.a.
4 30 Ewing sarcoma Proximal femur Distal 46 86.7 78.3
5 52 Osteosarcoma Distal femur Proximal 6∗ 90.8 86.7
21.46 months) for the longest case. The following table shows
the detailed patient data (Table 1). Within this mentioned
period of observation, there was no radiological or clinical
reported loosening of the implanted femoral spreading stem
(five patients with six fixations). Overall, the clinical follow-
up of this series is rather small mainly because this implant
was used in clinical high-risk situations and the majority
of patients in this series have died. The longest surviving
patient (number 4 of Table 1) was a 30-year-old female with
a pathological fracture through Ewing sarcoma. At the last
follow-up, she reported feeling so safe with her implant that
she even went skydiving.
4. Discussion
With the development of modern chemotherapy, limb sal-
vage surgery in femoral primary or metastatic lesions is
well established. Surgical reconstruction remains a challenge
when the remaining part of the femur is short, together
with the reverse funnel shape and its inherent problems as
to biomechanical forces. To anchor the femoral stem in the
remaining femoral bone, cement is most often used [8–12].
Several authors describe a high incidence of infection rate
and aseptic loosening of the femoral component [8–14]. Farid
and Finstein evaluated aseptic loosening with 10% as the
most common late complication in their serieswith cemented
endoprostheses of the proximal femur [9, 10]. In our case
series, we used a new type of rigid fixation for the femoral
stem after extensive resection of the femur without using
cement or interlocking pins. This prosthesis uses spreading
fins in the shaft to achieve rigid fixation in the residual
metaphyseal femoral bone. Due to the high-pressure bone-
implant interface attainedwith the spreading stem,we believe
that we present a new possible option for rigid fixation in
short remaining femoral bones.
A further possible option for reconstruction aftermassive
femoral resection was created by Johnson in 1994 by its
Compress prostheses [15]. Here, the fixation of the stem
in the remaining shaft results from interlocking cross-pins
and is supposed to create a rigid, high-pressure bone-implant
interface for biologic fixation. In a study by Farfalli et al.
[16], however, 12% of the patients (out of 41 with Compress
prostheses) had to undergo revision surgery due to fractures
and bone resorption within five years using such implants.
Interestingly, the revision surgery rate correlated with the
stem diameter, which seems to act as a predictor of implant
survival [17]. Even though the follow-up of our series is short,
we consider the uncemented spreading stem prostheses as an
option for thinner shafts where the Compress prostheses is,
due to the abovementioned reasons, not recommended.
Limitations of our study include the paucity of biome-
chanical studies that prove extrastability resulting from the
spreading stem and the absence of data describing the
stability against rotational forces to the spreading stem.
However, related to our preliminary clinical experience,
rotatory instability does not seem to be a problem in our
follow-up. Further, the overall follow-up in this series is short,
and the clinical scores vary. This is mainly explained by the
advanced (metastatic) stage of the diseases of the patients
included, which affected the functional score more than the
rigid fixation of the device in the bone.
Custom-made prostheses for the femur, which are indi-
vidually designed and manufactured, offer an additional
option in reconstruction after extensive resection of the
femur. These prostheses are mostly fixed via cortical flanges
or interlocking cross-pins [11, 13]. Nevertheless, Natarajan
et al. [11] reported a mechanical failure rate of over 13%,
even with these individual anatomical shaped prostheses.
Another attempt for rigid fixation in ultrashort metaphyseal-
condylar segments was described by Cannon et al. [18] with
cemented custom-made tumour endoprostheses and cross-
stem pin fixation in 32 patients. Their results showed a good
reconstructive success with a relatively low complication
rate but unfortunately, the company does not produce these
custom devices anymore. Disadvantages of these custom-
made solutions seem to be the individual manufacturing of
these prostheses, which can take some time and delay the
treatment of patients and therefore increase the morbidity
[19].
5. Conclusions
Based on our series, the spreading stem may represent an
additional alternative option for fixation of a prosthetic
device in the remaining femur after extensive tumour resec-
tion. Nevertheless, long-term follow-up of a larger series of
patients with this novel implant design is needed to stand the
test of time.
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